KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.40 $15.18 Thursday, 25th Apr 2024 ASMB stock ended at $13.36. This is 0.89% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.07% from a day low at $12.98 to a day high of $13.38.
90 days $0.82 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
Oct 30, 2020 $14.96 $14.96 $14.20 $14.74 240 106
Oct 29, 2020 $15.01 $15.49 $14.66 $14.99 275 758
Oct 28, 2020 $14.51 $15.68 $14.45 $14.92 452 344
Oct 27, 2020 $14.49 $15.09 $14.31 $14.81 384 120
Oct 26, 2020 $14.73 $15.15 $14.22 $14.54 249 318
Oct 23, 2020 $15.29 $15.40 $14.52 $14.87 268 858
Oct 22, 2020 $15.20 $15.84 $15.20 $15.42 249 588
Oct 21, 2020 $15.27 $15.74 $14.90 $15.48 287 864
Oct 20, 2020 $15.55 $15.99 $14.62 $15.35 308 960
Oct 19, 2020 $16.50 $16.62 $15.42 $15.55 229 107
Oct 16, 2020 $15.32 $15.93 $15.23 $15.62 153 313
Oct 15, 2020 $15.14 $15.51 $14.92 $15.42 115 620
Oct 14, 2020 $15.84 $16.00 $15.23 $15.44 169 875
Oct 13, 2020 $15.41 $15.86 $15.39 $15.73 215 631
Oct 12, 2020 $15.50 $15.65 $15.08 $15.53 118 426
Oct 09, 2020 $15.74 $15.84 $15.21 $15.42 146 582
Oct 08, 2020 $15.96 $15.96 $15.42 $15.67 172 532
Oct 07, 2020 $16.26 $16.38 $15.48 $15.73 234 637
Oct 06, 2020 $17.05 $17.21 $15.98 $16.25 206 661
Oct 05, 2020 $16.66 $17.50 $16.57 $16.99 261 456
Oct 02, 2020 $16.92 $17.15 $16.35 $16.53 187 542
Oct 01, 2020 $16.48 $17.29 $16.22 $17.29 267 273
Sep 30, 2020 $16.28 $16.94 $16.28 $16.44 237 700
Sep 29, 2020 $16.05 $16.63 $16.01 $16.25 135 243
Sep 28, 2020 $16.39 $16.53 $16.02 $16.16 138 584
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT